These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6116593)

  • 1. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists.
    Fuller RW; Snoddy HD
    Endocrinology; 1981 Oct; 109(4):1026-32. PubMed ID: 6116593
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide.
    Fuller RW; Snoddy HD; Mason NR; Clemens JA; Bemis KG
    Neuroendocrinology; 1983; 36(4):285-90. PubMed ID: 6866215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists.
    Fuller RW; Snoddy HD
    Neuropharmacology; 1984 Dec; 23(12A):1389-94. PubMed ID: 6527743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide.
    Fuller RW; Perry KW; Hemrick-Luecke SK
    Neurochem Res; 1982 Apr; 7(4):399-405. PubMed ID: 6125905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Sep; 34(9):607-8. PubMed ID: 6127394
    [No Abstract]   [Full Text] [Related]  

  • 6. Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
    Fuller RW; Hemrick-Luecke SK; Perry KW; Toomey RE
    J Pharm Pharmacol; 1985 Apr; 37(4):268-70. PubMed ID: 2860228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of pergolide to rats attenuates the acute elevation of serum corticosterone by pergolide.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1981 Dec; 15(6):933-6. PubMed ID: 7323119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flumezapine, an antagonist of central dopamine and serotonin receptors.
    Fuller RW; Mason NR
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):23-34. PubMed ID: 2879325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats.
    Gust CM; Fuller RW
    Neurosci Lett; 1988 Nov; 93(2-3):307-11. PubMed ID: 2907374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
    Jiang DH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
    Wong DT; Reid LR
    Commun Psychopharmacol; 1980; 4(4):269-75. PubMed ID: 7273702
    [No Abstract]   [Full Text] [Related]  

  • 15. Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain.
    Fuller RW; Snoddy HD
    Life Sci; 1983 Dec; 33(23):2357-61. PubMed ID: 6645804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW; Clemens JA; Hynes MD
    J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype.
    King BH; Brazell C; Dourish CT; Middlemiss DN
    Neurosci Lett; 1989 Oct; 105(1-2):174-6. PubMed ID: 2562060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.
    Dupont AG; Lefebvre RA; Bogaert MG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):146-51. PubMed ID: 4010793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.